Kimberly Wehger
Chief Tech/Sci/R&D Officer presso ARVINAS, INC.
Profilo
Kimberly Wehger è vicepresidente di Information Technology presso Arvinas, Inc. In passato la signora Wehger è stata Chief Information Officer & Vice President presso la New Haven Pharmaceuticals, Inc., Director-Business Engagement presso Alexion Pharmaceuticals, Inc. e Practice Manager-R&D Managed Services presso Veeva Systems, Inc. Ha conseguito una laurea presso la State University of New York a Binghamton e una laurea presso la Southern Connecticut State University.
Posizioni attive di Kimberly Wehger
Società | Posizione | Inizio |
---|---|---|
ARVINAS, INC. | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Kimberly Wehger
Società | Posizione | Fine |
---|---|---|
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Chief Tech/Sci/R&D Officer | 01/01/2016 |
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
VEEVA SYSTEMS INC. | Corporate Officer/Principal | - |
Formazione di Kimberly Wehger
Southern Connecticut State University | Graduate Degree |
State University of New York at Binghamton | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
VEEVA SYSTEMS INC. | Technology Services |
ARVINAS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Health Technology |
- Borsa valori
- Insiders
- Kimberly Wehger